Simulation of drug-drug interactions anticipate in vivo outcomes.
Fluorescent assay methods aid GPCR investigation in the discovery and development of therapeutic antibodies.
Pharmacokinetic assays have traditionally been a bottleneck in lead optimization, but a new generation of technologies is increasing the throughput of these critical tests.
TTP LabTech has joined forces with Platypus Technologies to offer automated solutions for studying the migration and invasion profiles of different cell lines using the Acumen eX3 laser scanning microplate cytometer.
Bausch + Lomb, the global eye health company, has named Daniel M. Wechsler as corporate vice president and global president of its Pharmaceuticals business.
French drugmaker Sanofi-Aventis SA is sticking to its original offer of $69 a share to buy U.S. biotech company Genzyme Corp., according to a Sanofi spokesman.
In a phase 3 study, researchers randomly assigned patients to one of three treatment groups: those receiving ipilimumab plus an inactive version of gp 100 (a cancer vaccine); those receiving ipilimumab plus gp 100; and those receiving gp 100 plus ipilimumab placebo.
Researchers have determined why certain stem cells are able to stay stem cells. An enzyme that changes the way DNA is packaged in cells allows specific genes to be turned on and off, thereby preventing a stem cell from becoming another cell type.
Shire plc announced the expansion of its Human Genetic Therapies pipeline through the exclusive license, in markets outside of North America, for the activin receptor type IIB (ActRIIB) class of molecules being developed by Acceleron Pharma Inc.
Daiichi Sankyo Company, Limited announced that the United States Court of Appeals has affirmed the U.S. District Court decision in patent litigation against Mylan, upholding the validity of the Daiichi Sankyo U.S. patent covering Benicar, Benicar HCT, and AZOR.
Federal health regulators are warning doctors that a class of injectable drugs used in MRI medical imaging scans can cause a rare and sometimes fatal condition in patients with kidney disease.
Doctors and AIDS activists urged African governments to fulfill a decade-old pledge to spend more of their own money on health if they want international help in fighting AIDS.
Affymetrix has launched the GeneAtlas System, which offers a complete personal solution for processing Affymetrix microarrays including stations for fluidics, imaging and hybridization, a computer workstation, and analysis software.
TTP LabTech has validated a new cell colony formation assay on the Acumen eX3 fluorescence microplate cytometer in collaboration with ChemPartner.